NEW YORK (Reuters) - A $117 million verdict against Johnson & Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term use of J&J's Baby Powder could open a new front for thousands of cases claiming the w...
Original Article: J&J Baby Powder litigation takes new focus with asbestos claims